Nieuws Regulated Oxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema EN NL november 20, 2023
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL november 19, 2023
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL november 16, 2023
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL november 15, 2023
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL november 6, 2023
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL november 3, 2023
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC EN NL oktober 30, 2023
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL oktober 20, 2023
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC EN NL oktober 20, 2023
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL oktober 10, 2023
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL oktober 3, 2023
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL september 27, 2023
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL september 18, 2023
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC EN NL september 18, 2023
Nieuws Regulated Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress to Topline Results in 2023 EN NL september 11, 2023
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL september 7, 2023
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL september 1, 2023
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL september 1, 2023
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL augustus 25, 2023
